MASSDEVICE ON CALL — Technology giant Samsung (LON:BC94) announced new healthcare features for upcoming models of its Gear smartphone-connected watches, which will include heart rate sensors and the company’s FDA-cleared S Health app.
Samsung Electronics Co. Ltd.
Samsung lands FDA clearance for health app
Samsung Electronics (LON:BC94) said it landed 510(k) clearance from the FDA for its S Health app.
The S Health app pulls biometric variables from 3rd-party devices, including calories burned, projected heart rate, blood glucose, blood pressure and sleep efficiency.
AirStrip partners with Samsung to bring mHealth solutions to smartphones, touchscreen PCs
Samsung puts more skin in medtech, nabs NeuroLogica in closed-doors deal
Technology titan Samsung Electronics (LON:BC94) made new moves in the medical device space with the stealthy buyout of Danvers, Mass.-based imaging devices maker NeuroLogica.
Covidien nabs Barrx for $325 million | Acquisitions Roundup
Covidien (NYSE:COV) agreed to acquire Sunnyvale, Calif.-based device maker Barrx Medical Inc. for $325 million.
Barrx, a private company, specializes in minimally invasive radiofrequency ablation systems that target precancerous tissue in the esophagus.
Report: Samsung looks to muscle in on GE, Siemens in the imaging market
Samsung aims to carve out medical device niche with new brand | Deals roundup
Samsung Electronics Co. Ltd. (KSE:005930.KS) launched a new corporate identity for medical products created through its collaboration with Korea based ultrasound equipment maker Medison Co.
The combined group, Samsung Medison, has a goal of becoming one of the world’s top 4 diagnostic ultrasound firms and, by 2020, aims to have 10,000 employees, according to the company.
